Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000886163-17-000108
Filing Date
2017-08-25
Accepted
2017-08-25 17:36:15
Documents
1
Period of Report
2017-08-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_150369696228577.html 4  
1 FORM 4 wf-form4_150369696228577.xml 4 4990
  Complete submission text file 0000886163-17-000108.txt   6392
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Issuer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address
Aryeh Jason (Reporting) CIK: 0001376960 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33093 | Film No.: 171052792